Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 2054 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
  Instructions 
  Search 
  IPS 
  My preferences 

 


This article has been cited by
1Association between serotonin-norepinephrine reuptake inhibitors and acute angle closure: What is known?
Michal Wicinski,Bartlomiej J. Kaluzny,Slawomir Liberski,Daria Marczak,Malgorzata Seredyka-Burduk,Katarzyna Pawlak-Osinska
Survey of Ophthalmology.2019;64(2)185
[DOI]
2Pharmacokinetic considerations for current state-of-the-art antidepressants
Elzbieta Wyska
Expert Opinion on Drug Metabolism & Toxicology.2019;15(10)831
[DOI]
3Desvenlafaxine vs. placebo in the treatment of persistent depressive disorder
David J. Hellerstein,Jonathan W. Stewart,Ying Chen,Vinushini Arunagiri,Bradley S. Peterson,Patrick J. McGrath
Journal of Affective Disorders.2019;245(10)403
[DOI]
4Transdermal Route: A Viable Option for Systemic Delivery of Antidepressants
Akeemat O. Tijani,Estefany Nunez,Karyn Singh,Garima Khanna,Ashana Puri
Journal of Pharmaceutical Sciences.2021;110(9)3129
[DOI]